Powder: -20°C for 3 years | In solvent: -80°C for 1 year
EP3 antagonist 4 is an EP3 antagonist that inhibits hEP with a Ki of 2 nM. EP3 antagonist 4 showed low in vivo clearance, high oral AUC and good bioavailability in complete PK studies in rats. EP3 antagonist 4 can be used to study diabetes and cellular dysfunction.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
1 mg | お問い合わせ | ¥ 45,000 |
5 mg | お問い合わせ | ¥ 99,000 |
10 mg | お問い合わせ | ¥ 149,500 |
25 mg | お問い合わせ | ¥ 255,000 |
50 mg | お問い合わせ | ¥ 385,500 |
100 mg | お問い合わせ | ¥ 583,000 |
500 mg | お問い合わせ | ¥ 1,282,500 |
説明 | EP3 antagonist 4 is an EP3 antagonist that inhibits hEP with a Ki of 2 nM. EP3 antagonist 4 showed low in vivo clearance, high oral AUC and good bioavailability in complete PK studies in rats. EP3 antagonist 4 can be used to study diabetes and cellular dysfunction. |
分子量 | 577.91 |
分子式 | C22H20Cl3FN4O3S2 |
CAS No. | 2408297-80-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
EP3 antagonist 4 2408297-80-1 GPCR/G Protein Immunology/Inflammation Prostaglandin Receptor Inhibitor inhibitor inhibit